BioDelivery Sciences International Inc. is a specialty pharmaceutical company that is commercializing new applications of proven applications. The company is currently focusing its efforts in the areas of pain management and oncology supportive care.
The company today announced that the commercial launch and availability of ONSOLIS (fentanyl buccal soluble film) in Canada will occur this quarter. ONSOLIS is approved in the US and Canada for the management of pain in opioid tolerant, adult patients with cancer. This product will be marketed in Canada by Meda Valeant Pharma Canada Incorporated, a joint venture between BioDelivery Sciences’ commercial partner for ONSOLIS, Meda, and Valeant Canada Limited.
Valeant Pharmaceuticals International Inc. is a specialty pharmaceutical company. In Canada, its portfolio includes products for the treatment of pain and oncology supportive care. This makes them an ideal partner for BioDelivery Sciences International and the commercialization of ONSOLIS.
The Canadian market will be of particular importance to BioDelivery Sciences. That is because ONSOLIS will be among the first products available in the country for the management of pain in patients undergoing cancer treatment that have a tolerance for opioids. The company also plans to introduce ONSOLIS soon in other markets such as Europe, where it is also approved and will be marketed as BREAKYL.
For more information on BioDelivery Sciences International, please visit the company’s website at www.bdsi.com
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment